Significance of continuous rotavirus and norovirus surveillance in Indonesia
- 212 Downloads
Diarrhea significantly contributes to the global burden of diseases, particularly in developing countries. Rotavirus and norovirus are the most dominant viral agents responsible for diarrheal disease globally. The aim of this review was to conduct a comprehensive assessment of rotavirus and norovirus study in Indonesia.
Articles about rotavirus and norovirus surveillance in Indonesia were collected from databases, including PubMed and Google Scholar. Manual searching was performed to identify additional studies. Furthermore, relevant articles about norovirus diseases were included.
A national surveillance of rotavirus-associated gastroenteritis has been conducted for years, resulting in substantial evidence about the high burden of the diseases in Indonesia. In contrast, norovirus infection received relatively lower attention and very limited data are available about the incidence and circulating genotypes. Norovirus causes sporadic and epidemic gastroenteritis globally. It is also emerging as a health problem in immunocompromised individuals. During post-rotavirus vaccination era, norovirus potentially emerges as the most frequent cause of diarrheal diseases.
Our review identifies knowledge gaps in Indonesia about the burden of norovirus diseases and the circulating genotypes. Therefore, there is a pressing need to conduct national surveillance to raise awareness of the community and national health authority about the actual burden of norovirus disease in Indonesia. Continuing rotavirus surveillance is also important to assess vaccine effectiveness and to continue tracking any substantial changes of circulating rotavirus genotypes.
KeywordsDiarrhea Rotavirus Norovirus Indonesia Surveillance
The authors thank Noviarina Kurniawati, Risky Oktriani, and Deanna Camell for critical reading of this manuscript.
HMS contributed to conception and design, article searching, acquisition of data and drafting the manuscript; NH, AAT and SY contributed to critical revision of the manuscript for important intellectual content; PQ contributed to conception and design, study supervision and critical revision of the manuscript for important intellectual content. All the authors have read and approved the final manuscript.
The Indonesia Endowment Fund for Education (LPDP) for funding Ph.D. fellowship to Mohamad S. Hakim.
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
- 2.Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar. 2013. http://www.depkes.go.id/resources/download/general/Hasil%20Riskesdas%202013.pdf. Accessed 31 July 2017.
- 3.Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia. 2015. http://www.depkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/profil-kesehatan-Indonesia-2015.pdf. Accessed 31 July 2017.
- 7.Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, World Health Organization-Coordinated Global Rotavirus Surveillance Network. Global, regional, and national estimates of rotavirus mortality in children < 5 years of age, 2000–2013. Clin Infect Dis. 2016;62(Suppl 2):S96–105.CrossRefPubMedGoogle Scholar
- 22.Pratiwi E, Setiawaty V, Putranto RH. Molecular characteristics of rotavirus isolated from a diarrhea outbreak in October 2008 in Bintuni Bay, Papua, Indonesia. Virology (Auckl). 2014;5:11–4.Google Scholar
- 27.Djojosugito FA, Savira M, Anggraini D, Putra AE. Identification of the P genotypes of rotavirus in children with acute diarrhea in Pekanbaru, Indonesia. Malays J Microbiol. 2017;13:67–72.Google Scholar
- 28.Banyai K, Laszlo B, Duque J, Steele AD, Nelson EA, Gentsch JR, et al. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine. 2012;30(Suppl 1):A122–30.CrossRefPubMedGoogle Scholar
- 32.World Health Organization. Rotavirus vaccines, WHO position paper—January 2013. Wkly Epidemiol Rec. 2013;88:49–64.Google Scholar
- 40.Hemming M, Rasanen S, Huhti L, Paloniemi M, Salminen M, Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr. 2013;172:739–46.CrossRefPubMedGoogle Scholar
- 50.Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep. 2011;60:1–18.Google Scholar
- 69.Centers for Disease C, Prevention. Emergence of new norovirus strain GII.4 Sydney-United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:55.Google Scholar